- ►diabetesjournals.org J Rosenstock, P Hollander, KM Gadde, X Sun, … - Diabetes care, 2007 - Am Diabetes Assoc RESULTS—A total of 111 subjects were randomized and analyzed. By the end of
week 16, patients in the placebo and topiramate groups lost 2.5 and 6.0 kg,
which represented 2.3 and 5.8%, respectively, of their baseline body weight ... Cited by 13 - Related articles - BL Direct - All 5 versions
H Toplak, A Hamann, R Moore, E Masson, M … - International Journal of Obesity, 2006 - nature.com This was a multicenter, double-blind, placebo-controlled trial. All subjects
received a non-pharmacological program of diet, exercise and behavioral
modification throughout the study; the assigned diet was 600 kcal/day less ... Cited by 20 - Related articles - BL Direct - All 6 versions
K Stenlof, S Rossner, F Vercruysse, A Kumar, … - Diabetes Obes Metab, 2007 - interscience.wiley.com Methods: Drug-naive individuals with type 2 diabetes, body mass index (BMI) of
≥27 and <50 kg/m 2 and haemoglobin A 1c (HbA 1c ) of <10.5% were enrolled into
the study. All the individuals participated in a non-pharmacologic weight ... Cited by 17 - Related articles - All 3 versions
J Rosenstock, P Hollander, KM Gadde - Am Diabetes Assoc A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the
Efficacy and Safety of Topiramate Controlled-Release in the Treatment of Obese,
Type 2 Diabetic Patients† ... Received for publication 25 September ... Related articles - All 2 versions
A Tremblay, JP Chaput, S Berube-Parent, D … - European journal of clinical pharmacology, 2007 - Springer Abstract Objective Topiramate (TPM) has been reported to reduce body weight
beyond a placebo in the treatment of obese participants, but the effect of this
agent on components of energy balance has not yet been established in ... Cited by 12 - Related articles - BL Direct - All 5 versions
Y Liang, X Chen, M Osborne, SO DeCarlo, TL … - Diabetes Obesity and Metabolism, 2005 - interscience.wiley.com Topiramate (TPM) is a novel neurotherapeutic agent. Clinical studies reported
that TPM treatment reduced body weight and decreased fasting blood glucose
levels in obese patients with or without type 2 diabetes. It is unclear ... Cited by 15 - Related articles - All 4 versions
E Ha, SV Yim, KH Jung, SH Yoon, LT Zheng, … - Pharmacogenomics Journal-Basingstoke, 2006 - khusm.khu.ac.kr E Ha1,2,6, SV Yim2,6, KH Jung2, SH Yoon2, LT Zheng2, MJ Kim3, SJ Hong4, BK
Choe2, HH Baik1, JH Chung2 and JW Kim2,5 ... 1Department of Biochemistry,
College of Medicine, Kyung Hee University, Seoul, Republic of Korea; ... Cited by 8 - Related articles - View as HTML - BL Direct - All 4 versions
[CITATION] for the OBDM-003 Study Group: Topiramate in the treatment of obese subjects with drug- …
K Stenlof, S Rossner, F Vercruysse, A Kumar, … - Diabetes Obes Metab, 2007 Cited by 4 - Related articles
[CITATION] Bupropion and zonisamide for the treatment of obesity
F Greenway, J Anderson, R Atkinson, K … - Program and abstracts of the Annual Scientific … Cited by 4 - Related articles
